{
  "resourceType" : "ValueSet",
  "id" : "2.16.840.1.113762.1.4.1196.4469",
  "meta" : {
    "versionId" : "10",
    "lastUpdated" : "2024-07-29T08:54:37.000-04:00",
    "profile" : [
      "http://hl7.org/fhir/StructureDefinition/shareablevalueset",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
    ]
  },
  "extension" : [
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/valueset-author",
      "valueContactDetail" : {
        "name" : "CDC DHP TEB Author"
      }
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
      "valueDate" : "2024-05-15"
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
      "valueDate" : "2024-05-15"
    }
  ],
  "url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.4469",
  "identifier" : [
    {
      "system" : "urn:ietf:rfc:3986",
      "value" : "urn:oid:2.16.840.1.113762.1.4.1196.4469"
    }
  ],
  "version" : "20240515",
  "name" : "CabotegravirInjectableProducts",
  "title" : "Cabotegravir Injectable Products",
  "status" : "active",
  "date" : "2024-05-15T01:01:25-04:00",
  "publisher" : "CDC DHP TEB Steward",
  "description" : "Under Cooperative Agreement number 6-NU38OT000316, funded by the CDC Division of Sexually Transmitted Disease Prevention and the Division of HIV Prevention, the Public Health Informatics Institute coordinated a project to test the feasibility, usability and acceptance of a CDS solution aimed at increasing adherence to public health guidelines for treating gonorrhea, encouraging human immunodeficiency virus screening and raising awareness of pre-exposure prophylaxis prescriptions in clinical settings. See https://phii.org/sti-connect-cds/ for full information.  This value set was created to support that work and could be used to inform the development of a similar solution in a clinical environment.  It is important to note that the CDS solution incorporated portions of public health guidelines for GC treatment, HIV screening and PrEP education and does not reflect a full implementation of the guidelines.",
  "jurisdiction" : [
    {
      "coding" : [
        {
          "system" : "urn:iso:std:iso:3166",
          "code" : "US"
        }
      ]
    }
  ],
  "purpose" : "(Clinical Focus: GPCK & BPCKs were added manually by finding codes in RxNav),(Data Element Scope: ),(Inclusion Criteria: ),(Exclusion Criteria: )",
  "compose" : {
    "include" : [
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "concept" : [
          {
            "code" : "2475408",
            "display" : "cabotegravir Injectable Product"
          },
          {
            "code" : "2475415",
            "display" : "{1 (3 ML cabotegravir 200 MG/ML Injection) / 1 (3 ML rilpivirine 300 MG/ML Injection) } Pack"
          },
          {
            "code" : "2475416",
            "display" : "{1 (3 ML cabotegravir 200 MG/ML Injection) / 1 (3 ML rilpivirine 300 MG/ML Injection) } Pack [CABENUVA 600 MG / 900 MG]"
          },
          {
            "code" : "2475417",
            "display" : "{1 (2 ML cabotegravir 200 MG/ML Injection) / 1 (2 ML rilpivirine 300 MG/ML Injection) } Pack"
          },
          {
            "code" : "2475418",
            "display" : "{1 (2 ML cabotegravir 200 MG/ML Injection) / 1 (2 ML rilpivirine 300 MG/ML Injection) } Pack [CABENUVA 400 MG / 600 MG]"
          },
          {
            "code" : "2588046",
            "display" : "Apretude Injectable Product"
          },
          {
            "code" : "2588076",
            "display" : "cabotegravir Injection"
          },
          {
            "code" : "2588077",
            "display" : "3 ML cabotegravir 200 MG/ML Injection"
          },
          {
            "code" : "2588078",
            "display" : "cabotegravir 200 MG/ML Injection"
          },
          {
            "code" : "2588079",
            "display" : "cabotegravir Injection [Apretude]"
          },
          {
            "code" : "2588080",
            "display" : "3 ML cabotegravir 200 MG/ML Injection [Apretude]"
          },
          {
            "code" : "2588081",
            "display" : "cabotegravir 200 MG/ML Injection [Apretude]"
          },
          {
            "code" : "2594978",
            "display" : "2 ML cabotegravir 200 MG/ML Injection"
          }
        ]
      }
    ]
  },
  "expansion" : {
    "identifier" : "urn:uuid:70ffe7ad-22fa-4ace-be40-e489931c62fb",
    "timestamp" : "2024-12-10T07:37:31-05:00",
    "total" : 11,
    "contains" : [
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11042024",
        "code" : "2475408",
        "display" : "cabotegravir Injectable Product"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11042024",
        "code" : "2475415",
        "display" : "{1 (3 ML cabotegravir 200 MG/ML Injection) / 1 (3 ML rilpivirine 300 MG/ML Injection) } Pack"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11042024",
        "code" : "2475416",
        "display" : "{1 (3 ML cabotegravir 200 MG/ML Injection) / 1 (3 ML rilpivirine 300 MG/ML Injection) } Pack [CABENUVA 600 MG / 900 MG]"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11042024",
        "code" : "2475417",
        "display" : "{1 (2 ML cabotegravir 200 MG/ML Injection) / 1 (2 ML rilpivirine 300 MG/ML Injection) } Pack"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11042024",
        "code" : "2475418",
        "display" : "{1 (2 ML cabotegravir 200 MG/ML Injection) / 1 (2 ML rilpivirine 300 MG/ML Injection) } Pack [CABENUVA 400 MG / 600 MG]"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11042024",
        "code" : "2588046",
        "display" : "Apretude Injectable Product"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11042024",
        "code" : "2588076",
        "display" : "cabotegravir Injection"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11042024",
        "code" : "2588077",
        "display" : "3 ML cabotegravir 200 MG/ML Injection"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11042024",
        "code" : "2588079",
        "display" : "cabotegravir Injection [Apretude]"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11042024",
        "code" : "2588080",
        "display" : "3 ML cabotegravir 200 MG/ML Injection [Apretude]"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11042024",
        "code" : "2594978",
        "display" : "2 ML cabotegravir 200 MG/ML Injection"
      }
    ]
  }
}
